Cargando…
Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055922/ https://www.ncbi.nlm.nih.gov/pubmed/33887318 http://dx.doi.org/10.1016/j.kint.2021.04.006 |
| _version_ | 1783680541834346496 |
|---|---|
| author | Yanay, Noa Berar Freiman, Sarit Shapira, Ma'anit Wishahi, Samar Hamze, Munir Elhaj, Mohamad Zaher, Maha Armaly, Zaher |
| author_facet | Yanay, Noa Berar Freiman, Sarit Shapira, Ma'anit Wishahi, Samar Hamze, Munir Elhaj, Mohamad Zaher, Maha Armaly, Zaher |
| author_sort | Yanay, Noa Berar |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8055922 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | International Society of Nephrology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80559222021-04-20 Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients Yanay, Noa Berar Freiman, Sarit Shapira, Ma'anit Wishahi, Samar Hamze, Munir Elhaj, Mohamad Zaher, Maha Armaly, Zaher Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2021-06 2021-04-20 /pmc/articles/PMC8055922/ /pubmed/33887318 http://dx.doi.org/10.1016/j.kint.2021.04.006 Text en © 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Yanay, Noa Berar Freiman, Sarit Shapira, Ma'anit Wishahi, Samar Hamze, Munir Elhaj, Mohamad Zaher, Maha Armaly, Zaher Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients |
| title | Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients |
| title_full | Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients |
| title_fullStr | Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients |
| title_full_unstemmed | Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients |
| title_short | Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients |
| title_sort | experience with sars-cov-2 bnt162b2 mrna vaccine in dialysis patients |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055922/ https://www.ncbi.nlm.nih.gov/pubmed/33887318 http://dx.doi.org/10.1016/j.kint.2021.04.006 |
| work_keys_str_mv | AT yanaynoaberar experiencewithsarscov2bnt162b2mrnavaccineindialysispatients AT freimansarit experiencewithsarscov2bnt162b2mrnavaccineindialysispatients AT shapiramaanit experiencewithsarscov2bnt162b2mrnavaccineindialysispatients AT wishahisamar experiencewithsarscov2bnt162b2mrnavaccineindialysispatients AT hamzemunir experiencewithsarscov2bnt162b2mrnavaccineindialysispatients AT elhajmohamad experiencewithsarscov2bnt162b2mrnavaccineindialysispatients AT zahermaha experiencewithsarscov2bnt162b2mrnavaccineindialysispatients AT armalyzaher experiencewithsarscov2bnt162b2mrnavaccineindialysispatients |